Yet many people don’t seem to recognize this—and this is a missed opportunity. Helping people to rethink side effects as ...

The Food and Drug Administration has approved updated COVID-19 vaccines to protect against currently circulating variants, and the shots have shown to be more effective than the now-available ...

One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, ...

The U.S. Food and Drug Administration recently green-lit new 2024-25 COVID-19 vaccinations ahead of the fall and winter seasons, when respiratory viruses spread more rapidly within communities.

Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...

Many healthy people have immunity from vaccines and previous infection. This is a KFF Health News story. The U.S. Food and Drug Administration has approved an updated COVID-19 shot for everyone 6 ...

One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, ...

AND CORONARY ARTERY DISEASE. THEY ARE THE HIGH RISK GROUP. HOW EFFECTIVE IS THE VACCINE? IT’S VERY EFFECTIVE. SO FAR. YOU NEED ONLY ONE VACCINE, BUT STUDIES ARE ONGOING TO DECIDE WHETHER ...

A single dose of chikungunya vaccine is safe, effective, provides protection up to 2 years, and does not result in any long-term serious AEs related to vaccination.

“We found that vaccination of older adults may be less costly and more effective than no vaccination and that vaccinating people aged 70 years and older with chronic medical conditions is likely ...

Researchers have shown that they can generate a strong immune response against HIV with two doses of a vaccine given one week apart.